Ayala Corporation - AYALY

AYALY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
AYALY	0	0	7.4	24.1	25.4	21.2	-30.2	-26.2	-21.1	17.4
S&P 500	-0.6	-0.5	1.5	9.1	13.4	32.3	27.0	92.1	191.7	33587.3

Compare AYALY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	AYALY
name	Ayala Corporation
price	12.35
changes percentage	0
change	0
day low	12.35
day high	12.35
year high	999
year low	9.6
market cap	7701422950
price avg 50	11.8406
price avg 200	11.0768
exchange	PNK
volume	100
avg volume	100
open	12.35
previous close	None
eps	1.1
pe	11.23
earnings announcement	2024-11-13T03:08:00.000+0000
shares outstanding	623597000
timestamp	2024-11-14 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 41.7%

Overall Quarterly Financial Health: 50.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	341897736000	270515384000	26.39
gross profit	121183141000	59946660000	102.15
gross profit ratio	0.35	0.22	59.95
research and development expenses	499279000	229827000	117.24
operating expenses	36321751000	27430648000	32.41
interest income	8521640000	1076374000	691.70
interest expense	28217952000	25884106000	9.02
ebitda	51361129000	93643915000	-45.15
ebitdaratio	0.15	0.35	-57.43
operating income	84861390000	79798299000	6.34
operating income ratio	0.25	0.29	-15.86
net income	38073084000	45873931000	-17.00
net income ratio	0.11	0.17	-34.33
eps	56.06	74.06	-24.30

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 341,898 million in 2023 from 270,515 million in 2022 representing a change of 26.39%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 121,183 million in 2023 from 59,947 million in 2022 representing a change of 102.15%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 499 million in 2023 from 230 million in 2022 representing a change of 117.24%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 84,861 million in 2023 from 79,798 million in 2022 representing a change of 6.34%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 36,322 million in 2023 from 27,431 million in 2022 representing a change of 32.41%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 51,361 million in 2023 from 93,644 million in 2022 representing a change of -45.15%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 38,073 million in 2023 from 45,874 million in 2022 representing a change of -17.0%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 56.06 in 2023 from 56.06 in 2022 representing a change of -24.3%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	92672927000	75727546000	22.38
gross profit	34632665000	19505643000	77.55
gross profit ratio	0.37	0.26	45.09
research and development expenses	0	0	NaN
operating expenses	16195847000	11442937000	41.54
interest income	3043242000	3033275000	0.33
interest expense	8271126000	7946098000	4.09
ebitda	22773177000	30973895000	-26.48
ebitdaratio	0.25	0.41	-39.92
operating income	0	27008273000	-100.00
operating income ratio	0	0.36	-100.00
net income	9213701000	13072786000	-29.52
net income ratio	0.1	0.17	-42.41
eps	13.58	20.44	-33.56

Overall Score of Quarterly Income Statement

0.43 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 92,673 million in 2024Q2 from 75,728 million in 2024Q1 representing a change of 22.38%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 34,633 million in 2024Q2 from 19,506 million in 2024Q1 representing a change of 77.55%. This indicates a sales profitability growth, which is a positive sign for the company.

  Net Income: Net income increased to 9,214 million in 2024Q2 from 13,073 million in 2024Q1 representing a change of -29.52%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 16,196 million in 2024Q2 from 11,443 million in 2024Q1 representing a change of 41.54%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 22,773 million in 2024Q2 from 30,974 million in 2024Q1 representing a change of -26.48%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 0 million in 2024Q2 from 27,008 million in 2024Q1 representing a change of -100.0%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 13.58 in 2024Q2 from 13.58 in 2024Q1 representing a change of -33.56%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1608713290000	1478545136000	8.80
total liabilities	933771929000	883246092000	5.72
total equity	677640292000	595299044000	13.83
cash and cash equivalents	85103544000	73847371000	15.24
short term investments	8733903000	14878175000	-41.30
long term investments	391297249000	343471631000	13.92
total current assets	575495486000	541782240000	6.22
total non current assets	1035916734999	936762896000	10.58
total current liabilities	349362933000	309014757000	13.06
total non current liabilities	584408996000	574231335000	1.77
common stock	31475111000	31719396000	-0.77
retained earnings	297882907000	267836258000	11.22
total debt	620549273000	614328049000	1.01

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,608,713 million in 2023 from 1,478,545 million in 2022 representing a change of 8.8%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 677,640 million in 2023 from 595,299 million in 2022 representing a change of 13.83%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 85,104 million in 2023 from 73,847 million in 2022 representing a change of 15.24%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 575,495 million in 2023 from 541,782 million in 2022 representing a change of 6.22%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 297,883 million in 2023 from 267,836 million in 2022 representing a change of 11.22%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 933,772 million in 2023 from 883,246 million in 2022 representing a change of 5.72%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 8,734 million in 2023 from 14,878 million in 2022 representing a change of -41.3%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 349,363 million in 2023 from 309,015 million in 2022 representing a change of 13.06%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 31,475 in 2023 from 31,719 in 2022 representing a change of -0.77%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 620,549 million in 2023 from 614,328 million in 2022 representing a change of 1.01%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1678647387000	1641244072000	2.28
total liabilities	972986315000	944679266000	3.00
total equity	708609051000	696564806000	1.73
cash and cash equivalents	78759593000	69497246000	13.33
short term investments	7964088000	9827808000	-18.96
long term investments	398024207000	397926856000	0.02
total current assets	591654746000	578868817000	2.21
total non current assets	1089940619999	1062375255000	2.59
total current liabilities	369096974000	334502511000	10.34
total non current liabilities	603889341000	610176755000	-1.03
common stock	31478227000	31752613000	-0.86
retained earnings	318532234000	310506550000	2.58
total debt	644298863000	635679847000	1.36

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,678,647 million in 2024Q2 from 1,641,244 million in 2024Q1 representing a change of 2.28%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 708,609 million in 2024Q2 from 696,565 million in 2024Q1 representing a change of 1.73%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 78,760 million in 2024Q2 from 69,497 million in 2024Q1 representing a change of 13.33%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 591,655 million in 2024Q2 from 578,869 million in 2024Q1 representing a change of 2.21%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 318,532 million in 2024Q2 from 310,507 million in 2024Q1 representing a change of 2.58%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 972,986 million in 2024Q2 from 944,679 million in 2024Q1 representing a change of 3.0%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 7,964 million in 2024Q2 from 9,828 million in 2024Q1 representing a change of -18.96%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 369,097 million in 2024Q2 from 334,503 million in 2024Q1 representing a change of 10.34%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 31,478 in 2024Q2 from 31,753 in 2024Q1 representing a change of -0.86%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 644,299 million in 2024Q2 from 635,680 million in 2024Q1 representing a change of 1.36%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	9810061000	-16636538000	158.97
operating cash flow	14476456000	18718762000	-22.66
free cash flow	-27891380000	-14768718000	-88.85
capital expenditure	-42367836000	-33487480000	-26.52
depreciation and amortization	14480754000	15671969000	-7.60
deferred income tax	-35676233000	0	NaN
stock based compensation	114645000	94116000	21.81
accounts payables	20259099000	20233631000	0.13
inventory	-22106446000	-19292166000	-14.59
acquisitions net	7614551000	-9614315000	179.20
investments in property plant and equipment	-41302400000	-33487480000	-23.34
net cash used for investing activites	-55309897000	-68812125000	19.62
debt repayment	39830999000	63837128000	-37.61
common stock issued	11442000	8513000	34.41
common stock repurchased	0	-688285000	100.00
dividends paid	-9341869000	-8182808000	-14.16
net cash used provided by financing activities	41690637000	34681143000	20.21
cash at end of period	85103544000	73847371000	15.24
accounts receivables	-4752733000	-14509697000	67.24
cash at beginning of period	75293483000	90483909000	-16.79

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 9,810 million in 2023 from -16,637 million in 2022 representing a change of 158.97%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -42,368 million in 2023 from -33,487 million in 2022 representing a change of -26.52%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 14,476 million in 2023 from 18,719 million in 2022 representing a change of -22.66%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -27,891 million in 2023 from -14,769 million in 2022 representing a change of -88.85%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 115 million in 2023 from 94 million in 2022 representing a change of 21.81%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 20,259 million in 2023 from 20,234 million in 2022 representing a change of 0.13%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -4,753 in 2023 from -14,510 million in 2022 representing a change of 67.24%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -9,342 million in 2023 from -8,183 million in 2022 representing a change of -14.16%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	234955000	3696708000	-93.64
free cash flow	-18386711000	-6395764000	-187.48
capital expenditure	-18621666000	-10092472000	-84.51
depreciation and amortization	4336359000	3965622000	9.35
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-19139044000	-3244787000	-489.84
accounts payables	2367597000	385423000	514.29
inventory	-3919381000	1721556000	-327.67
acquisitions net	-3111413000	-2489923000	-24.96
investments in property plant and equipment	-18621666000	-10092472000	-84.51
net cash used for investing activites	9163315000	-19905316000	146.03
debt repayment	-1606132000	13046038000	-112.31
common stock issued	-360000	400000	-190.00
common stock repurchased	0	0	NaN
dividends paid	368701000	-4198861000	108.78
net cash used provided by financing activities	-2677338000	10650325000	-125.14
net change in cash	-924509000	-5286976000	82.51
cash at end of period	78759593000	69497246000	13.33
cash at beginning of period	79684102000	74784222000	6.55

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -925 million in 2024Q2 from -5,287 million in 2024Q1 representing a change of 82.51%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -18,622 million in 2024Q2 from -10,092 million in 2024Q1 representing a change of -84.51%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -19,139 million in 2024Q2 from -3,245 million in 2024Q1 representing a change of -489.84%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 369 million in 2024Q2 from -4,199 million in 2024Q1 representing a change of 108.78%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 235 million in 2024Q2 from 3,697 million in 2024Q1 representing a change of -93.64%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -18,387 million in 2024Q2 from -6,396 million in 2024Q1 representing a change of -187.48%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 2,368 million in 2024Q2 from 385 million in 2024Q1 representing a change of 514.29%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	526.56	436.72	20.57
net income per share	58.64	74.06	-20.82
operating cash flow per share	22.3	30.22	-26.22
free cash flow per share	-42.96	-23.84	-80.16
cash per share	144.52	143.24	0.89
book value per share	1039.49	961.05	8.16
tangible book value per share	977.29	888.47	10.00
shareholders equity per share	614.87	592.59	3.76
interest debt per share	951.89	933.73	1.95
market cap	388209664915.2	400006675328	-2.95
enterprise value	923655393915.2	940487353328	-1.79
pe ratio	10.2	8.72	16.94
price to sales ratio	1.14	1.48	-23.21
pocfratio	26.82	21.37	25.49
pfcf ratio	-13.92	-27.08	48.61
pb ratio	0.97	1.09	-10.77
ptb ratio	0.97	1.09	-10.77
ev to sales	2.7	3.48	-22.29
enterprise value over ebitda	17.98	10.04	79.06
ev to operating cash flow	63.8	50.24	26.99
ev to free cash flow	-33.12	-63.68	48.00
earnings yield	0.1	0.11	-14.48
free cash flow yield	-0.07	-0.04	-94.59
debt to equity	1.48	1.51	-1.84
debt to assets	0.37	0.37	-1.88
net debt to ebitda	10.43	5.77	80.63
current ratio	1.65	1.75	-6.05
interest coverage	3.01	3.08	-2.45
income quality	0.38	0.36	5.80
dividend yield	0.02	0.02	17.63
payout ratio	0.25	0.18	37.56
sales general and administrative to revenue	0.1	0.02	376.43
research and ddevelopement to revenue	0.0	0.0	71.89
intangibles to total assets	0.03	0.03	-17.44
capex to operating cash flow	2.93	1.79	63.59
capex to revenue	0.12	0.12	0.10
capex to depreciation	2.93	2.14	36.93
stock based compensation to revenue	0.0	0.0	-3.62
graham number	900.68	993.7	-9.36
roic	0.04	0.08	-47.08
return on tangible assets	0.02	0.03	-24.14
graham net net	-938.83	-919.98	-2.05
working capital	226132553000	232767483000	-2.85
tangible asset value	634557499000	550341685000	15.30
net current asset value	-358276443000	-341463852000	-4.92
invested capital	439069318000	414700160000	5.88
average receivables	149371162000	156506850500	-4.56
average payables	127084269000	114976813500	10.53
average inventory	230959355000	183961990500	25.55
days sales outstanding	142.56	222.91	-36.05
days payables outstanding	219.54	210.46	4.32
days of inventory on hand	430.63	349.31	23.28
receivables turnover	2.56	1.64	56.36
payables turnover	1.66	1.73	-4.14
inventory turnover	0.85	1.04	-18.88
roe	0.1	0.12	-23.69
capex per share	65.25	54.06	20.70

• ROE:

  Debt-to-Equity Ratio:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 10.20 on 2023-12-31 from 8.72 on 2022-12-31, representing a change of 16.94%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.65 on 2023-12-31 from 1.75 on 2022-12-31, representing a change of -6.05%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
AYALY
calendar year	2024	2024	NaN
revenue per share	142.76	122.18	16.85
net income per share	14.19	21.09	-32.70
operating cash flow per share	0.36	5.96	-93.93
free cash flow per share	-28.33	-10.32	-174.49
cash per share	133.6	127.98	4.39
book value per share	1087.08	1123.84	-3.27
tangible book value per share	1024.51	1059.9	-3.34
shareholders equity per share	650.54	667.21	-2.50
interest debt per share	957.6	989.41	-3.22
market cap	364428768038.4	387306206783.65	-5.91
enterprise value	929968038038.4	953488807783.65	-2.47
pe ratio	9.89	7.41	33.50
price to sales ratio	3.93	5.11	-23.11
pocfratio	1551.06	104.77	1380.43
pfcf ratio	-19.82	-60.56	67.27
pb ratio	0.86	0.94	-7.86
ptb ratio	0.86	0.94	-7.86
ev to sales	10.03	12.59	-20.30
enterprise value over ebitda	40.84	30.78	32.66
ev to operating cash flow	3958.07	257.93	1434.56
ev to free cash flow	-50.58	-149.08	66.07
earnings yield	0.03	0.03	-25.10
free cash flow yield	-0.05	-0.02	-205.53
debt to equity	1.45	1.46	-0.77
debt to assets	0.37	0.37	-0.93
net debt to ebitda	24.83	18.28	35.86
current ratio	1.6	1.73	-7.37
interest coverage	0	3.4	-100.00
income quality	0.01	0.19	-93.52
dividend yield	0.0	0.01	-90.67
payout ratio	0.04	0.32	-87.54
sales general and administrative to revenue	0.17	0.15	15.66
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.02	0.02	0.19
capex to operating cash flow	79.26	2.73	2803.03
capex to revenue	0.2	0.13	50.77
capex to depreciation	4.29	2.54	68.74
stock based compensation to revenue	0	0	NaN
graham number	455.8	562.7	-19.00
roic	0	0.02	-100.00
return on tangible assets	0.01	0.01	-31.09
graham net net	-955.37	-1003.14	4.76
working capital	222557772000	244366306000	-8.92
tangible asset value	665045889000	656931060000	1.24
net current asset value	-381331569000	-365810449000	-4.24
invested capital	460612129000	463398024000	-0.60
average receivables	169551623500	149546948500	13.38
average payables	142734529500	135754686000	5.14
average inventory	255373853499.5	249634945500	2.30
days sales outstanding	168.54	196.76	-14.34
days payables outstanding	227.5	222.12	2.42
days of inventory on hand	421.59	382.38	10.25
receivables turnover	0.53	0.46	16.75
payables turnover	0.4	0.41	-2.37
inventory turnover	0.21	0.24	-9.30
roe	0.02	0.03	-30.98
capex per share	28.69	16.28	76.17

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-06-30 Q2 from 0.03 on 2024-03-31 Q1, representing a change of -30.98%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.89 on 2024-06-30 Q2 from 7.41 on 2024-03-31 Q1, representing a change of 33.50%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.60 on 2024-06-30 Q2 from 1.73 on 2024-03-31 Q1, representing a change of -7.37%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None